Number of the records: 1
glukagón
SYS d005934 LBL 00000cz--a2200000n--4500 005 20250606213412.3 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a D06.472.699.587.730.500 065 $a D12.644.548.586.730.500 066 $a 01 $c 03 150 $a glukagón $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a HG-faktor $2 slo 450 $w v $a faktor hyperglykemicko-glykogenolytický $2 slo 450 $w v $a proglukagón (33-61) $2 slo 450 $w v $a glukagón (1-29) $2 slo 550 $7 sllk_us_auth*d005765 $Y Gastrointestinal Agents $w P $a látky gastrointestinálne 550 $7 sllk_us_auth*d006728 $Y Hormones $w P $a hormóny 550 $7 sllk_us_auth*d018027 $Y Receptors, Glucagon $w p $a receptory glukagónové 550 $7 sllk_us_auth*d018027 $Y Receptors, Glucagon $w b $a receptory glukagónové 680 9-
$i A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) $2 eng 680 $a do not confuse with GLUCAGON-LIKE PEPTIDES secreted by the intestine $2 eng 750 -2
$a Glucagon $2 eng 980 $x M
Number of the records: 1